With more than 2.2 million new cases and nearly 1.8 million deaths in 2020, lung cancer represents 11.4% of the 19,292,789 new cases of cancer worldwide and 18% of its mortality. (1)
A lot of debate and research have been generated in the last few years about the efficacy of lung cancer screening, the cost-effectiveness of its implementation, and the future impact that emerging technologies such as deep learning and biomarkers might have on the process.
Chaired by Rosa Giuliani, ESMO Director of Public Policy, the seventh instalment in the World Cancer Report Updates webinar series, “The Present and Future of Lung Cancer Screening: Latest Evidence and Research Perspectives” will offer oncologists the opportunity to learn about and take stock of the situation on lung cancer prevention.
The webinar, free upon registration, will be broadcast live on the IARC platform on Tuesday, 6 December 2022 at 14:00 CET, and will delve into three questions:
- What is the current evidence on lung cancer screening?
- How can risk prediction and biomarkers contribute to make lung cancer screening more effective and efficient?
- What role could artificial intelligence play in lung cancer screening?
Professor Joachim Aerts, Head of the Department of Pulmonary Medicine at the Erasmus University Medical Center, The Netherlands, will discuss the latest state of affairs of the published data on lung cancer screening.
Dr Hilary Robbins, Scientist in the Genomic Epidemiology Branch at the International Agency for Research on Cancer (IARC), will discuss how lung cancer screening programmes can be made more effective and efficient by using information about individual risk to tailor aspects of eligibility, screening frequency, and nodule follow-up. Her presentation will explore research developments in predicting lung cancer occurrence using statistical models, blood-based biomarkers, and artificial intelligence with low-dose computed tomography (CT) images.
The World Cancer Report Updates webinar series aims to provide new perspectives or present new research, to complement the large variety of educational resources based on selected content of IARC’s World Cancer Report. These educational resources are freely accessible from the World Cancer Report Updates learning platform, which was developed by IARC with the support of and in collaboration with ESMO.